Zobrazeno 1 - 1
of 1
pro vyhledávání: '"chronic hepatitis C, drug drug interactions, virus genotype 1, treatment experienced patients, pump inhibitor use, combination therapy, treatment naive, liver fibrosis,grazoprevir, elbasvir"'
Autor:
Quaranta M. G., Rosato S., Ferrigno L., Amoruso D. C., Monti M., Di Stefano P., Filomia R., Biliotti E., Migliorino G., Russo F. P., Degasperi E., Chemello L., Brancaccio G., Blanc P., Cannizzaro M., Barbaro F., Morsica G., Licata A., Kondili L. A., on behalf of PITER Collaborating group, Federico A., Dallio M., Loguercio C.
Publikováno v:
Antiviral therapy. 25(2)
Background In patients treated for HCV infection, potential drug–drug interactions (DDIs) can occur among direct-acting antiviral drugs (DAAs) and comedications used. The real-life effectiveness and safety of elbasvir/grazoprevir (ELB/GZR) among co